averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HES1 | hg19_v2_chr3_+_193853927_193853944 | -0.12 | 7.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_7023491 Show fit | 13.21 |
ENST00000541477.1
ENST00000229277.1 |
enolase 2 (gamma, neuronal) |
|
chr3_-_138763734 Show fit | 9.00 |
ENST00000413199.1
ENST00000502927.2 |
proline rich 23C |
|
chr19_-_1652575 Show fit | 8.86 |
ENST00000587235.1
ENST00000262965.5 |
transcription factor 3 |
|
chr12_+_7023735 Show fit | 8.42 |
ENST00000538763.1
ENST00000544774.1 ENST00000545045.2 |
enolase 2 (gamma, neuronal) |
|
chr20_-_43280325 Show fit | 7.55 |
ENST00000537820.1
|
adenosine deaminase |
|
chr9_+_91926103 Show fit | 6.70 |
ENST00000314355.6
|
CDC28 protein kinase regulatory subunit 2 |
|
chr2_-_73511559 Show fit | 6.51 |
ENST00000521871.1
|
F-box protein 41 |
|
chr20_-_3154162 Show fit | 6.47 |
ENST00000360342.3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
|
chr1_-_32801825 Show fit | 6.13 |
ENST00000329421.7
|
MARCKS-like 1 |
|
chr5_+_156693091 Show fit | 6.11 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
cytoplasmic FMR1 interacting protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 24.1 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.4 | 18.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 14.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.5 | 14.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
4.1 | 12.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
4.0 | 11.9 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
1.5 | 11.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 10.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
3.2 | 9.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
3.2 | 9.6 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 22.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
3.6 | 21.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.0 | 18.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 12.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 12.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 11.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 11.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 8.9 | GO:0043679 | axon terminus(GO:0043679) |
0.3 | 8.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 8.6 | GO:0031965 | nuclear membrane(GO:0031965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 21.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.0 | 18.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.3 | 14.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
4.1 | 12.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
4.0 | 11.9 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.2 | 10.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 9.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.1 | 9.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.8 | 8.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 8.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 13.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 11.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 8.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 7.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 6.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 6.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 6.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 5.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 4.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 35.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 21.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 18.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 14.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 12.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.7 | 10.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 9.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 7.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 7.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 6.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |